Trial Profile
Conversion to tacrolimus meltdose (Envarsus), a PK guided evaluation study in stable liver transplant recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Apr 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Pharmacokinetics
- 30 Mar 2021 Results published in the British Journal of Clinical Pharmacology
- 30 Mar 2021 Status has been changed to completed according to results published in the British Journal of Clinical Pharmacology.
- 05 Feb 2018 New trial record